drugset / Trial / NCT00617409

To Immunize Patients With Extensive Stage SCLC Combined With Chemo With or Without All Trans Retinoic Acid

NCT00617409

RandomizedFactorialOpen-labelTreatment

Summary

The purpose of this research study is to test a tumor (cancer) vaccine given along with chemotherapy to determine if this vaccine will increase the chances of the tumor shrinking and/or the amount of time that people who have this disease will live.

Timeline

Start
2007-10-02
Primary completion
2015-09-21
Completion
2019-01-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Ad.p53-DC vaccines Vaccine 1e+06 cells Other
Subject Ad.p53-DC vaccines Vaccine 5e+06 cells Other
Subject Tretinoin Small molecule 150 mg/m2
Background Paclitaxel Small molecule 200 mg/m2